With elite athletes like LeBron James and Cristiano Ronaldo as investors, the company, now valued at $10 billion, is courting everyday health enthusiasts.
Category: Medical Devices
-
Whoop, a Wearable Health Device Maker, Raises $575 Million
The New York Times – Business: -
Whoop, a Wearable Health Device Maker, Raises $575 Million
The New York Times – Business:With elite athletes like LeBron James and Cristiano Ronaldo as investors, the company, now valued at $10 billion, is courting everyday health enthusiasts.
-
Boston Scientific Knew of Pacemaker Battery Problems for Years
The New York Times – Business:Boston Scientific announced multiple recalls but has said its battery issues were limited. One internal test in 2025 found batteries with an “extremely high failure rate.”
-
New Method Can Find Hidden Eggs to Aid in Fertility Treatment
The New York Times – Business:A study reported that the conventional method of searching follicular fluid didn’t find all the eggs. The new technology found extra eggs more than half the time.
-
F.D.A. Looks to A.I. to Enhance Efficiency
With a Trump-driven reduction of nearly 2,000 employees, agency officials view artificial intelligence as a way to speed drugs to the market.
-
Trump’s Next Tariffs Target Could be Foreign-Made Pharmaceuticals
President Trump wants to bring pharmaceutical manufacturing back to the United States. Experts warn that tariffs could result in shortages and higher prices for generic drugs.
-
FDA-Approved Artificial Blood Vessel Stirs Concerns
The F.D.A. approved an artificial vessel to restore blood flow in patients, despite its own scientists flagging questionable study results and potentially fatal ruptures of the product.
-
For Patients Needing Transplants, Hope Arrives on Tiny Hooves
Some scientists are confident that organs from genetically modified pigs will one day be routinely transplanted into humans. But substantial ethical questions remain.
-
FDA Staffed Up to Review AI and Food Safety. Those Hires Are Now Gone.
Teams evaluating high-tech surgical robots and insulin-delivery systems were gutted by Trump layoffs even though industry fees, not taxpayers, financed the employee salaries.
-
ExThera Claimed Its Device Could Cure Cancer. But Patients Died.
Two U.S. companies teamed up to treat cancer patients using an unproven blood filter in Antigua, out of reach of American regulators.